A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results.

about

A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results.

Item

http://www.wikidata.org/entity/Q55129591

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

A feasibility and safety study ...... d tumors: Preliminary results.

@en

A feasibility and safety study ...... d tumors: Preliminary results.

@nl

type

Item

label

A feasibility and safety study ...... d tumors: Preliminary results.

@en

A feasibility and safety study ...... d tumors: Preliminary results.

@nl

prefLabel

A feasibility and safety study ...... d tumors: Preliminary results.

@en

A feasibility and safety study ...... d tumors: Preliminary results.

@nl

P1476

A feasibility and safety study ...... d tumors: Preliminary results.

@en

P2093

Chenping Zhang

http://www.w3.org/2001/XMLSchema#string

Guopei Zhu

http://www.w3.org/2001/XMLSchema#string

Min Ruan

http://www.w3.org/2001/XMLSchema#string

Rongrong Li

http://www.w3.org/2001/XMLSchema#string

Shengjin Dou

http://www.w3.org/2001/XMLSchema#string

P2860

Salivary Gland Cancers: Biology and Systemic Therapy

mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy.

Thymidylate synthase expression as a predictive biomarker of pemetrexed sensitivity in advanced non-small cell lung cancer.

Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer

Cytochrome 450 1B1 (CYP1B1) polymorphisms associated with response to docetaxel in Castration-Resistant Prostate Cancer (CRPC) patients.

RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab.

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients.

Association between TYMS expression and efficacy of pemetrexed-based chemotherapy in advanced non-small cell lung cancer: a meta-analysis.

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients.

Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?

P304

e0564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000010564

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29703045

http://www.w3.org/2001/XMLSchema#string

P932

5944525

http://www.w3.org/2001/XMLSchema#string